AzTrials
AzTrials

Depression DisordersNCT06740084

African Youth in Mind (Y-MIND) - Pilot Feasibility Trial of a Brief Psychological Intervention for Older Adolescents With Depression Delivered Through Senior High Schools in Navrongo, Ghana

A study testing Y-MIND Intervention in people with Depression Disorders, run by King's College London at 1 site in Ghana.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The overarching aim of this pilot study is to assess the feasibility of implementing a psychological intervention (Y-MIND), delivered by school guidance and counselling coordinators, for the treatment of depression among adolescents in senior high schools in Ghana. Read more about this study

Who is it for?
Ages 15 to 18 years
Conditions the study is for
Depression Disorders
What is being tested?
Y-MIND Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteGhana
Study dates
1 Jul 2024to 1 Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Adolescents aged 15 to 18 years in senior high schools located within the Kassena-Nankana Municipality and Kassena-Nankana West District
  • Have scored 10 or more on the locally validated Patient Health Questionnaire-9 (PHQ-9)
  • be willing and able to be followed up for 5 months and provide informed consent or assent
  • For adolescents 15-17 years participants must have 5) access to a caregiver to obtain informed consent
  • All participants must have the ability to read, write and communicate in English language.

Who cannot join

  • are currently receiving any psychological treatment (talking therapy) for any common mental disorder through formal health care services
  • have active bipolar disorder or psychosis (assessed through a brief screening tool for bipolar disorder and psychosis)
  • have advanced or chronic physical illness (assessed through self-report)
  • have significant visual or hearing impairment which would interfere with their ability to take part in the study
  • are actively suicidal (assessed through the use of a four-item screening tool administered by a psychiatric nurse and reviewed by the trial clinical psychologist

Trial locations and contacts

1 site in 1 country.

Ghana1 site
  • Navrongo Health Research Centre

    Navrongo

Other trials in Ghana

About this study

The overarching aim of this pilot study is to assess the feasibility of implementing a psychological intervention (Y-MIND), delivered by school guidance and counselling coordinators, for the treatment of depression among adolescents in senior high schools in Ghana. The study is a parallel arm cluster randomised controlled pilot trial. We will recruit adolescents aged 15 to 18 years in senior high schools. Participants will be randomised to receive the Y-MIND psychological intervention or enhanced usual care.

Being tested
Y-MIND Intervention, Enhanced Usual Care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Y-MIND InterventionBehavioural

    All participants in the intervention arm will receive the EUC plus the Y-Mind intervention. Y-Mind intervention will be delivered by trained and supervised Guidance and Counselling Coordinators (GCC) at schools in 6 sessions. The six sessions will include a) psychoeducation on depression, b) behavioural activation (helping the participant see the connection between their behaviour, daily activities, and low mood and activity scheduling) and c) problem-solving therapy (the GCC helps the participant identify and define a specific problem to work on, evaluate the potential solutions to the problem, and carry out the selected solution(s)).

  • Enhanced Usual CareOther

    Enhanced Usual Care (EUC): Guidance and counselling coordinators in the schools provide some counselling to students who need it. Building on the existing structure, enhanced usual care in the Y-mind programme, will be enhanced in three ways: 1) Teaching staff will receive basic training on common mental health conditions affecting youth in Ghana with an emphasis on depression and suicidal symptoms and treatment. The WHO guidelines for school health services will form the basis for the training for teachers. 2) Nurses in all schools and other relevant local health care professionals will be trained in mental health, substance-use and self-harm including guidelines on when and where to refer young people for psychiatric care. The World Health Organization (WHO) Mental Health Gap intervention guide (mhGAP) will be used for training of nurses and other health care professionals . 3) The study team will provide a letter for the Guidance and Counselling Coordinators for the participant.

Study groups in NCT06740084
Study groupRoleWhat they receive
Enhanced Usual CareActive comparatorEnhanced Usual Care (EUC): Guidance and counselling coordinators in the schools provide some counselling to students who need it. Building on the existing structure, enhanced usual care in the Y-MIND programme, will be enhanced in three ways 1) Teaching staff will receive basic training on common mental health conditions affecting youth in Ghana with an emphasis on depression and suicidal symptoms and treatment. 2) Nurses in all schools and other relevant local health care professionals will be trained in mental health, substance-use and self-harm including guidelines on when and where to refer young people for psychiatric care. 3) The study team will provide a letter for the Guidance and Counselling Coordinators for the participant.
Receives: Other: Enhanced Usual Care
Y-MIND InterventionExperimentalAll participants in the intervention arm will receive the EUC plus the Y-Mind intervention. Y-Mind intervention will be delivered by trained and supervised Guidance and Counselling Coordinators (GCC) at schools in 6 sessions. The six sessions will include a) psychoeducation on depression, b) behavioural activation (helping the participant see the connection between their behaviour, daily activities, and low mood and activity scheduling) and c) problem-solving therapy (the GCC helps the participant identify and define a specific problem to work on, evaluate the potential solutions to the problem, and carry out the selected solution(s)).
Receives: Behavioral: Y-MIND Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of the intervention

    Feasibility of the intervention will be measured using the 'Feasibility of Intervention Measure' (FIM) with adolescents who received the Y-MIND intervention.

    Measured: At the end of treatment (week 6) (or at their 5 months post baseline assessment if the treatment sessions were not attended)

  2. Symptoms of depression

    Symptoms of depression at 5 months post baseline assessment measured as the difference in mean score on the Patient Health Questionnaire-9 (PHQ-9) between the two arms. Difference in mean PHQ-9 would likely constitute a primary outcome in a later larger definitive trial.

    Measured: 5 months post baseline assessment

Secondary outcomes (5)
  1. Acceptability and appropriateness of the intervention

    Acceptability and appropriateness of the intervention will be measured using the Intervention Appropriateness Measure (IAM), Acceptability of Intervention Measure (AIM) with adolescents at the end of their last intervention session (or at their 5 month post baseline assessment if the intervention session was not attended), and with Guidance and Counselling Coordinators at schools after they have finished delivering all intervention sessions.

    Acceptability will also be explored through interviews with adolescents (at end of 5 months post baseline assessment) and focus group discussions with Guidance and Counselling Coordinators (after they have finished delivering all intervention sessions) to elicit feasibility, acceptability, appropriateness and barriers and or enablers that may influence the effectiveness of the intervention.

    Measured: At end of Y-MIND intervention sessions or at 5 months post baseline assessment

  2. Feasibility of the intervention (Guidance and Counselling Coordinators)

    Feasibility of the intervention from the perspective of the Guidance and Counselling Coordinators, will also be measured using the Feasibility of Intervention Measure (FIM) with Guidance and Counselling Coordinators.

    Measured: At the end of treatment delivery

  3. Fidelity to delivering the psychological intervention

    Fidelity to delivering the psychological intervention, defined as the extent to which the intervention was delivered as intended, and measured by rating 20% of randomly selected audio-recorded psychological intervention sessions in the experimental arm using a culturally adapted form of ENACT called the 'Problem-Solving Therapy Fidelity Scale (PROOF)' tool.

    Measured: From the first treatment session (week 1) to the end of treatment (week 6)

  4. Symptoms of anxiety

    Symptoms of anxiety at 5 months post baseline assessment measured as the difference in mean score on the General Anxiety Disorder scale (GAD-7) between the two arms.

    Measured: 5 months post baseline assessment

  5. Alcohol use

    Alcohol use measured as the difference in mean score on the Alcohol Use Disorders Identification Test (AUDIT)

    Measured: 5 months post baseline assessment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2024
  2. Study start1 Jul 2024
  3. Primary completion1 Feb 2025
  4. Study completion1 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06740084
Sponsor's protocol ID
HR/DP-23/24-38948
Other IDs
NIHR133384
Status last verified
Mar 2026
First submitted
9 Dec 2024
Last updated
13 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Weobong B, Hodsoll J, Akanlu AG, Adde KS, Attah DA, Adagnera J, Awine T, Bawa S, Jopling R, Owusu BA, Bere T, Owusu L, Anyorikeya M, Nyamayaro P, Adams S, Achana F, Dambayi E, Ayuure C, Heller DJ, Yaro PB, Adongo PB, Glozah FN, Aborigo R, Barrett B, Smith P, Kumwenda M, Chibanda D, Abas M, Goldsmith K; *Y-MIND consortium. A lay teacher-counsellor delivered brief psychological treatment for moderate to severe depression among older adolescents in senior high schools in Ghana (Y-MIND): a feasibility cluster randomized controlled trial. medRxiv [Preprint]. 2026 Oct 11:2026.10.08.26364988. doi: 10.64898/2026.10.08.26364988.

    PubMed 42926966
  • Attah DA, Bere CT, Smith P, Adde KS, Bawa S, Achana F, Owusu L, Dambayi E, Ayuure C, Jopling R, Glozah F, Aborigo R, Chibanda D, Abas M, Weobong B. The African youth in mind (Y-MIND) brief psychological intervention for depression among school-going adolescents in Ghana: a development case series. BMC Psychiatry. 2026 Mar 5;26(1):304. doi: 10.1186/s12888-026-07938-w.

    PubMed 41787357
  • Jopling R, Attah D, Abas M, Adde KS, Goldsmith K, Bere T, Nyamayaro P, Aborigo RA, Barrett B, Owusu L, Glozah F, Akanlu A, Bawa S, Achana FS, Danese A, Smith P, Seward N, Kumwenda M, Chibanda D, Weobong B. African Youth in Mind - Protocol of a Pilot feasibility trial of a brief psychological Intervention for older adolescents with depression delivered through senior high schools in Navrongo, Ghana. PLoS One. 2025 Apr 1;20(4):e0319462. doi: 10.1371/journal.pone.0319462. eCollection 2025.

    PubMed 40168302

Questions about this trial

What is this clinical trial studying?

A study testing Y-MIND Intervention in people with Depression Disorders, run by King's College London at 1 site in Ghana.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ghana. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of the intervention (time frame: At the end of treatment (week 6) (or at their 5 months post baseline assessment if the treatment sessions were not attended)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06740084, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in